EUREOS & TIGERS 4th Joint Webinar

The fourth joint webinar on Challenges in EoE will take place on Weds 10th Nov, and will feature talks on epidemiology and risk factors and less invasive diagnosis and monitoring. Read more

IES Abstract Presentations

The International Eosinophil Society webinar on the 6th October featured - Abstract Presentations from 6 speakers and breakout rooms. More info and catch up recordings are available. Read more

EUREOS EoE 2021 Symposium

EUREOS' 2021 Scientific Symposium on EoE returns on October 4th. It is completely virtual and will feature talks on Real-world EoE registry data, a patient follow-up project and novel therapeutic options. Includes more information and registration details. Read more

Researchers Answer Your Questions

August 2021 - Together with CEGIR and other patient advocacy groups, we've developed a survey to have your EGID questions answered by global researchers. Read more

ESPGHAN - EGID Monothematic Conference

ESPGHAN's monothematic conference will take place in Athens on 4th - 6th November. Details on how to apply can be found here. Read more

AGA - Eosinophils in Gastrointestinal Disease: Pathways and Crossroads

A two day conference hosted by the AGA, the 2021 James W. Freston Single Topic Conference is about eosinophils in gastrointestinal disease pathways and crossroads. Here is an overview and links. Read more

Jorveza NICE UK Approval

June 2021 - Information on NICE's approval for Jorveza budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis, including links to the latest guidelines. Read more

IES webinar: Eosinophil Interactions with Non-Immune Cells

May 2021 - The topic of the next International Eosinophil Society webinar will be interactions with non immune cells. Find the speakers, event info and registration link here. Read more

Paediatric EoE survey

A UK and Ireland survey on the management of paediatric eosinophilic oesophagitis for gastroenterologists. Read more

EUREOS & TIGERS 3rd Joint Webinar

The next joint webinar from EUREOS and TIGERS will take place on June 16th. Here's the speakers, registration and agenda for the virtual event Read more

Digestive Disease Week & Medscape CME Session

May 2021 - The annual Digestive Disease Week is coming up on the 21st - 23rd of May, with all three days featuring talks on EGIDs. There is also a Medscape CME live session on lower EGIDs that is available to DDW ticket holders. Read more

Dupilimab Improves EoE Symptoms

Mar 2021 - Phase 3 trial shows Dupilimab to improve health-related quality of life and reduces symptom burden in patients with EoE. Read more

Budesonide Oral Suspension Effective in Paediatric EoE

Mar 2021 - Study finds Budesonide Oral Suspension improves multiple outcomes for children 11-17 with EoE. The drug taken twice-daily improved histologic, endoscopic, and combined histologic and symptomatic outcomes in children with EoE. Read more

Food Obstruction Action Plan update

Jan 2021 - We need you to answer our survey to help us develop an action plan for when food gets stuck in the oesophagus. Help us get it right! Read more

EUREOS & TIGERS 2nd Joint Webinar

Following November's success, EUREOS and TIGERS hosted another interactive webinar on March 3rd. Talks include dietary treatments in EoE and monitoring treatment response. Catch up on the recording Read more

Eosinophils and COVID Virtual Seminar

Jan 2021 - The International Eosinophil Society (IES) is holding a virtual seminar on 'Eosinophils and COVID'. Talks will include the involvement of eosinophils in viral infections, Covid-19 and eosinophilic diseases, and vaccine hypersensitivity. Read more

US Grants Priority Review for New EoE Treatment

Jan 2021 - The US FDA has granted priority review for Takeda's new budesonide oral suspension for treatment of eosinophilic oesophagitis (EoE). If successful, TAK-721 will be the first EoE treatment to be approved in the US. Read more

Phase 3 trial for Fasenra in EoE begins

Dec 2020 - AstraZeneca has begun its Phase 3 trial evaluating Fasenra in EoE and other eosinophilic diseases. It has also announced a further Phase 3 trial evaluating the drug for EG and EGE. Read more

Screening data from ENIGMA study reveals under-diagnosis of EG and EGE

Nov 2020 - Growing evidence that Eosinophilic Gastritis and Eosinophilic Gastroenteritis are under-diagnosed. 58% of moderate-severely symptomatic patients without diagnoses who entered the ENIGMA study met histologic criteria for EG/EGE Read more

ENIGMA Lirentelimab lower EGID study published

Nov 2020 - Allakos have published the results of the ENIGMA Phase 2 study of Lirentelimab for EG and EGE patients, showing meaningful and statistically significant benefits. The study appears in the October 2020 edition of the NEJM Read more

EUREOS & TIGERS Joint Webinar

Nov 2020 - On November 30th, EUREOS and TIGERS are holding the first joint meeting on Challenges in EoE, a global webinar for HCPs, researchers and industry representatives. Read more

Dupilumab EoE Treatment Phase 3 Trial

Oct 2020 - Dupixent® (dupilumab) Late-breaking Pivotal Data Showing Significant Improvement in Eosinophilic Esophagitis Signs and Symptom Read more